Scott Stephen Schaefer - 01 Nov 2026 Form 3 Insider Report for HERBALIFE LTD. (HLF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
06 Nov 2026, 16:43:58 UTC
Next SEC filing
06 Nov 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Alaaeddine Sahibi, as Attorney-In-Fact for Scott Schaefer
Filing notes and source

Key filing fact

Scott Stephen Schaefer filed Form 3 for HERBALIFE LTD. (HLF) on 06 Nov 2026.

Key facts

  • This page summarizes Scott Stephen Schaefer's Form 3 filing for HERBALIFE LTD. (HLF).
  • 0 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Nov 2026, 16:43.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002162531 Primary reporting owner

Schaefer Scott Stephen

Relationship
Chief Financial Officer
Address
800 W. OLYMPIC BLVD., SUITE 406, LOS ANGELES
Signature
Alaaeddine Sahibi, as Attorney-In-Fact for Scott Schaefer
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLF holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,500
Date
01 Nov 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HLF holding Derivative

Stock Appreciation Rights

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
61,983
Exercise price
$9.05
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported shares are held in a joint tenancy with right of survivorship account with the reporting person's spouse.

Footnote F2

On November 10, 2025, the reporting person was granted 61,983 stock appreciation rights ("SARs") under Herbalife Ltd. Amended and Restated 2023 Stock Incentive Plan. These SARs will vest in one-third increments on November 10, 2026, November 10, 2027, and November 10, 2028, subject to continued employment through such date.

SEC remarks

Exhibit List: Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .